Factors that interfere with the quality of warfarin treatment in patients with atrial fibrillation in the real-world context

Authors

DOI:

https://doi.org/10.30968/jhphs.2025.162.1308

Abstract

Objective: To characterize patients with atrial fibrillation (AF) treated at an anticoagulation clinic in Brazil who use warfarin and to identify factors associated with the quality of oral anticoagulation, measured by the Time in Therapeutic Range (TTR). Methods: Crosssectional study conducted between April and July 2019, involving patients with AF using warfarin under outpatient follow-up. The Mini-Mental State Examination (MMSE), the Short Assessment of Health Literacy for Portuguese-speaking Adults (SAHLPA-18), and the Oral Anticoagulation Knowledge (OAK) Test were applied. TTR was calculated based on the International Normalized Ratio (INR) and was considered adequate when ≥60%. Pharmacotherapy complexity was assessed using the Medication Regimen Complexity Index (MRCI). Data were analyzed using Student’s t-test, Chi-square or Fisher’s exact test, and logistic regression to calculate the odds ratio (OR). Results: The mean age of the 82 patients was 66.77 ± 9.54 years, with a predominance of males (52.44%). Most patients had low health literacy (75.58%) and 37.21% were using highly complex pharmacotherapies. Female sex and pharmacotherapy complexity were significantly associated with TTR < 60% (p < 0.05). Conclusion: The control of oral anticoagulation with warfarin may be influenced by factors such as sex and therapeutic complexity. Targeted interventions, including intensive pharmaceutical follow-up and educational strategies, may enhance therapeutic effectiveness in patients with AF.

Downloads

Download data is not yet available.

References

Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373-498. doi: 10.1093/eurheartj/ehaa612

Marianelli M, Marianelli C, Neto TPL, et al. Main risk factors for ischemic stroke: Adescriptive approach. Braz J Health Rev. 2020;3(6):19679-19690. doi: 10.34119/bjhrv3n6-344

Chylova M, Motovska Z, Fialova A, Stetkarova I, Peisker T, Kalvach P. The effect of warfarin administration on platelet aggregation. Bratisl Lek Listy. 2021;122(5):320-324. doi:10.4149/BLL_2021_054

ISMP Brasil, Prevenção de erros de medicação entre pacientes em uso de anticoagulantes orais. Boletim ISMP Brasil. 2020;V(9):2-11.

Wang M, Zeraatkar D, Obeda M, et al. Drug-drug interactions with warfarin: A systematic review and meta-analysis. Br J Clin Pharmacol. 2021;87(11):4051-4100. doi:10.1111/bcp.14833

Silva PGMBE, Sznejder H, Vasconcellos R, et al. Anticoagulation Therapy in Patients with Non-valvular Atrial Fibrillation in a Private Setting in Brazil: A Real-World Study. Arq Bras Cardiol. 2020;114(3):457-466. doi:10.36660/abc.20180076

Martinelli Filho M. Anticoagulation Therapy with Warfarin: A Reality of Brazilian Public Health that Lacks Structure for Better Control. Terapia de Anticoagulação com Varfarina: Uma Realidade da Saúde Pública Brasileira que Carece de Estrutura para Melhor Controle. Arq Bras Cardiol. 2022;119(3):370-371. doi:10.36660/abc.20220504

Leal PM, Amante LN, Girondi JBR, et al. Building solutions for the safety of the patient with heart disease using warfarin: A qualitative study. Texto Contexto Enferm. 2020;V(29) doi: 10.1590/1980-265X-TCE-2018-0002

Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198. doi:10.1016/0022-3956(75)90026-6

Brucki SM, Nitrini R, Caramelli P, Bertolucci PH, Okamoto IH. Sugestões para o uso do mini-exame do estado mental no Brasil. Arq Neuropsiquiatr. 2003;61(3B):777-781. doi:10.1590/s0004-282x2003000500014

Apolinario D, Braga Rde C, Magaldi RM, et al. Short Assessment of Health Literacy for Portuguese-speaking Adults. Rev Saude Publica. 2012;46(4):702-711. doi:10.1590/s0034-89102012005000047

Cavalcanti EO, Figueiredo PS, Santos LC, et al. Aportaciones de la alfabetización en salud a la seguridad del paciente en atención primaria: una revisión de alcance. Aquichan. 2024;24(1):1424. doi: 10.5294/aqui.2024.24.1.4

Skoumalova I, Kolarcik P, Madarasova Geckova A, et al. Is Health Literacy of Dialyzed Patients Related to Their Adherence to Dietary and Fluid Intake Recommendations?. Int J Environ Res Public Health. 2019;16(21):4295. doi:10.3390/ijerph16214295

Ministério da Saúde, Secretaria de Vigilância em Saúde. Saúde Brasil 2013: uma análise da situação de saúde e das doenças transmissíveis relacionadas à pobreza. Brasília: Ministério da Saúde, 2014.

Cabellos-García AC, Martínez-Sabater A, Díaz-Herrera MÁ, Gea-Caballero V, Castro-Sánchez E. Health literacy of patients on oral anticoagulation treatment- individual and social determinants and effect on health and treatment outcomes. BMC Public Health. 2021;21(1):1363. doi:10.1186/s12889-021-11259-w

Martins MAP, Costa JM, Mambrini JVM, et al. Health literacy and warfarin therapy at two anticoagulation clinics in Brazil. Heart. 2017;103(14):1089-1095. doi:10.1136/heartjnl-2016-310699

Marcolino MS, Sales TLS, Oliveira JA, et al. Health Literacy, Patient Knowledge and Adherence to Oral Anticoagulation in Primary Care. Int J Cardiovasc Sci. 2023;(36):e20220158 doi: 10.36660/ijcs.20220158

FIELD, A. Discovering statistics using IBM SPSS statistics, 5 ed. London: SAGE; 2018

Canio WC. Polypharmacy in Older Adults. Clin Geriatr Med. 2022;38(4):621-625. doi:10.1016/j.cger.2022.05.004

Davies LE, Spiers G, Kingston A, Todd A, Adamson J, Hanratty B. Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews. J Am Med Dir Assoc. 2020;21(2):181-187. doi:10.1016/j.jamda.2019.10.022

Soares AV, et al. Análise da composição corporal de mulheres idosas institucionalizadas com síndrome da fragilidade. Revista Nutrição em Pauta. 2019;(51):17-22 doi: 10.56579/rei.v6i2.951

Stone VE, Hogan JW, Schuman P, et al. Antiretroviral regimen complexity, self-reported adherence, and HIV patients’ understanding of their regimens: survey of women in the her study. J Acquir Immune Defic Syndr. 2001;28(2):124-131. doi:10.1097/00042560-200110010-00003

Muller IM. Improving the safety of direct oral anticoagulants through a multidisciplinary approach: lessons from a French retrospective cohort study. Thrombosis Journal. 2022; 20(1):1-12

Kim DH, Pawar A, Gagne JJ, et al. Frailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial Fibrillation : A Cohort Study. Ann Intern Med. 2021;174(9):1214-1223. doi:10.7326/M20-7141

Ko D, Rahman F, Martins MA, et al. Atrial fibrillation in women: treatment. Nat Rev Cardiol. 2017;14(2):113-124. doi:10.1038/nrcardio.2016.171

Penttilä T, Lehto M, Niiranen J, et al. Differences in the risk of stroke, bleeding events, and mortality between female and male patients with atrial fibrillation during warfarin therapy. Eur Heart J Cardiovasc Pharmacother. 2019;5(1):29-36. doi:10.1093/ehjcvp/pvy026

Downloads

Published

2025-06-27

How to Cite

1.
SANTOS LP, MARTINS MA, SANTOS GP, VIEIRA GS, MACHADO CJ, COSTA JM. Factors that interfere with the quality of warfarin treatment in patients with atrial fibrillation in the real-world context. J Hosp Pharm Health Serv [Internet]. 2025Jun.27 [cited 2025Jun.30];16(2):e1308. Available from: https://jhphs.org/sbrafh/article/view/1308

Issue

Section

ORIGINAL ARTICLES

Most read articles by the same author(s)